What is the most recent earnings date for VISTN stock?
VISTIN PHARMA ASA (VISTN.OL) last reported earnings on 2/12/2026.
OSL:VISTN • NO0010734122
Past quarterly earnings results for VISTIN PHARMA ASA (VISTN.OL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in NOK): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | - | - | 110.744M | - | -2.25% | |||
| Q3 2025 | - | - | 108.84M | - | 2.84% | |||
| Q2 2025 | - | - | 117.67M | - | 10.92% | |||
| Q1 2025 | - | - | 115.037M | - | 10.74% | |||
| Q4 2024 | - | - | 113.288M | - | 5.11% | |||
| Q3 2024 | - | - | 105.838M | - | -11.76% | |||
| Q2 2024 | - | - | 106.081M | - | -0.61% | |||
| Q1 2024 | - | - | 103.884M | - | 2.92% | |||
| Q4 2023 | - | - | 107.784M | - | 14.96% | |||
| Q3 2023 | - | - | 119.938M | - | 30.77% | |||
| Q2 2023 | - | - | 106.729M | - | 54.70% | |||
| Q1 2023 | - | - | 100.94M | - | 203.86% | |||
| Q4 2022 | - | - | 93.754M | - | 24.49% | |||
| Q3 2022 | - | - | 91.714M | - | 45.92% | |||
| Q2 2022 | - | - | 68.989M | - | 3.20% | |||
| Q1 2022 | - | - | 33.219M | - | -53.08% | |||
| Q4 2021 | - | - | 75.309M | - | 18.27% | |||
| Q3 2021 | - | - | 62.854M | - | 14.16% | |||
| Q2 2021 | - | - | 66.847M | - | -8.46% | |||
| Q1 2021 | - | - | 70.803M | - | 15.86% | |||
| Q4 2020 | - | - | 63.675M | - | - | |||
| Q3 2020 | - | - | 55.056M | - | - | |||
| Q2 2020 | - | - | 73.021M | - | - | |||
| Q1 2020 | - | - | 61.111M | - | - |
Notes
VISTIN PHARMA ASA (VISTN.OL) last reported earnings on 2/12/2026.
VISTIN PHARMA ASA (VISTN.OL) missed EPS estimates and missed revenue estimates in the most recent quarter.